I thought your comment that the spinout of Chemours had nothing to do with reducing the liability of DuPont was patently false.
Harley Rouda: “I thought your comment that the spinout of Chemours had nothing to do with reducing the liability of DuPont was patently…”
Editor's note · Context
Rouda criticizes claims about the Chemours spinout and its relation to DuPont's liabilities.
Share
More from Harley Rouda
A one percent under count of low-income workers in my district means a loss of approximately $160,000 in Federal funding for job training programs, apprenticeship programs, and career counseling.
I do not think the Green New Deal is the way to do it, but I do think that we have the capacity, the intellectual, technical capacity to address these issues and do it in a way that not only benefits our country but the whole world.
The essential nature of the prescription drugs and treatments you manufacture make it all the more vital for us to ensure their continued availability and affordability for all.
As you know, there is a bipartisan bill sitting on Mitch McConnell's desk that would eliminate the prefunding mandate and free up tens of billions of dollars for the U.S. Postal Service.





